This research study is evaluating whether primary palliative care is an alternative strategy to specialty palliative care for improving quality of life, sympto…

Relapsed Adult AMLPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT05237258

Observational

Multi-Site Randomized Controlled Trial of a Novel Digital Application (DREAMLAND) to Improve Outcomes for Patients With Acute Myeloid Leukemia

This research study is evaluating to examine the efficacy of a novel a self-administered digital application (DREAMLAND) for improving patients' long-term qual…

Relapsed Adult Acute Myeloid LeukemiaPrimary Refractory Acute Myeloid LeukemiaHigh Risk Acute Myeloid Leukemia

~Estimated

~$10 – $6,250

Massachusetts General HospitalNCT06472128